Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Basic & Clinical Pharmacology & Toxicology
|
August 8, 2008
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity
Stephen Toovey, Leyla Y Bustamante, Anne-Catrin Uhlemann, et al.
British Journal of Clinical Pharmacology
|
September 11, 2018
Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children
Trevor N Johnson, Yumi Cleary, Neil Parrott, et al.
British Journal of Clinical Pharmacology
|
May 14, 2015
Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria
Borje Darpo, Georg Ferber, Peter Siegl, et al.
Travel Medicine and Infectious Disease
|
May 13, 2017
Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis
Anne Novitt-Moreno, Janet Ransom, Geoffrey Dow, et al.
Travel Medicine and Infectious Disease
|
September 2, 2008
Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Luc Van Nassauw, Stephen Toovey, Joeri Van Op den Bosch, et al.
Vaccine
|
February 18, 2022
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Nancy Dreyer, Matthew W Reynolds, Lisa Albert, et al.
International Journal of General Medicine
|
August 4, 2021
Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
Nancy Dreyer, Natalia Petruski-Ivleva, Lisa Albert, et al.
Travel Medicine and Infectious Disease
|
December 3, 2014
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers
Stephen Toovey, Keith Nieforth, Patrick Smith, et al.
American Journal of Perinatology
|
May 6, 2022
COVID-19 Vaccinations in Pregnancy: Comparative Evaluation of Acute Side Effects and Self-Reported Impact on Quality of Life between Pregnant and Nonpregnant Women in the United States
Emma Brinkley, Christina DeFilippo Mack, Lisa Albert, et al.
Infection and Drug Resistance
|
September 12, 2022
COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness
Matthew W Reynolds, Yiqiong Xie, Kendall B Knuth, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Basic & Clinical Pharmacology & Toxicology
|
August 8, 2008
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity
Stephen Toovey, Leyla Y Bustamante, Anne-Catrin Uhlemann, et al.
British Journal of Clinical Pharmacology
|
September 11, 2018
Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children
Trevor N Johnson, Yumi Cleary, Neil Parrott, et al.
British Journal of Clinical Pharmacology
|
May 14, 2015
Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria
Borje Darpo, Georg Ferber, Peter Siegl, et al.
Travel Medicine and Infectious Disease
|
May 13, 2017
Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis
Anne Novitt-Moreno, Janet Ransom, Geoffrey Dow, et al.
Travel Medicine and Infectious Disease
|
September 2, 2008
Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Luc Van Nassauw, Stephen Toovey, Joeri Van Op den Bosch, et al.
Vaccine
|
February 18, 2022
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Nancy Dreyer, Matthew W Reynolds, Lisa Albert, et al.
International Journal of General Medicine
|
August 4, 2021
Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
Nancy Dreyer, Natalia Petruski-Ivleva, Lisa Albert, et al.
Travel Medicine and Infectious Disease
|
December 3, 2014
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers
Stephen Toovey, Keith Nieforth, Patrick Smith, et al.
American Journal of Perinatology
|
May 6, 2022
COVID-19 Vaccinations in Pregnancy: Comparative Evaluation of Acute Side Effects and Self-Reported Impact on Quality of Life between Pregnant and Nonpregnant Women in the United States
Emma Brinkley, Christina DeFilippo Mack, Lisa Albert, et al.
Infection and Drug Resistance
|
September 12, 2022
COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness
Matthew W Reynolds, Yiqiong Xie, Kendall B Knuth, et al.
Page
of 6